Q3 Medical

Q3 Medical is a medical device company focused on the development and manufacturing of novel bioresorbable and metallic implants for interventional cardiology, radiology, and gastroenterology. The company specializes in biodegradable polymer technology, creating stents and other devices designed to dissolve after their clinical purpose is served, thereby reducing long-term complications. Their product portfolio includes the ARCHIMEDES biodegradable biliary and pancreatic stent, which is the first of its kind to receive CE Mark approval. Q3 Medical operates through several subsidiaries, including QualiMed and AMG, to distribute its interventional products globally. The company aims to replace traditional permanent metallic implants with advanced bioresorbable solutions across multiple therapeutic areas.